$OS Therapies (OSTX.US)$OS Therapies Provides Regulatory Update on Rare Pediatric Cancer Immunotherapy Candidate OST-HER2 for Human Osteosarcoma 52 SECONDS AGO, 7:40 AM EDT VIA BUSINESSWIRE ▪ Dialogue open with FDA in preparation for End of Phase 2 Meeting request ▪ New canine elite responder biomarkers added to human biomarker strategy OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company...
$OS Therapies (OSTX.US)$ Cancer Treatment Breakthrough: OS Therapies Locks Down Critical Patent Protection - Will This Transform Osteosarcoma Treatment?
$OS Therapies (OSTX.US)$Still a low float bio-tech play with potential.. Closed up around 12% and volume at 38.7m. Support holding steady around $2, resistance between $2.50 and $2.60 is still key. The VMACD is hinting at upward trend,. If it can breakout above resistance, maybe we will get a renewed upward trend. BLA submission for OST-HER2 should be a good catalyst.
2
4
Report
MrNastyPaws OKMoo
:
Nice. Do you think it’s wise to enter now or do you think it will drop it all or is it a wait and see.? I assume you’re already in it to a degree I don’t own any. What would you be thinking if you were me?
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
OS Therapies Stock Forum
OS Therapies Hits Major Milestone: Phase 2b Cancer Trial Complete, FDA Filing Next
Breakthrough Pediatric Cancer Treatment Sets FDA Filing Timeline: Key Dates for Revolutionary Osteosarcoma Therapy
52 SECONDS AGO, 7:40 AM EDT
VIA BUSINESSWIRE
▪ Dialogue open with FDA in preparation for End of Phase 2 Meeting request
▪ New canine elite responder biomarkers added to human biomarker strategy
OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company...
Towards the abyss and descent
Breakthrough Osteosarcoma Drug Data Revealed: OS Therapies Fast-Tracks FDA Approval Path
Cancer Treatment Breakthrough: OS Therapies Locks Down Critical Patent Protection - Will This Transform Osteosarcoma Treatment?
BLA submission for OST-HER2 should be a good catalyst.
No comment yet